Your browser doesn't support javascript.
loading
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial.
Kelly, Ciara M; Antonescu, Cristina R; Bowler, Timothy; Munhoz, Rodrigo; Chi, Ping; Dickson, Mark A; Gounder, Mrinal M; Keohan, Mary Louise; Movva, Sujana; Dholakia, Reena; Ahmad, Hamza; Biniakewitz, Matthew; Condy, Mercedes; Phelan, Haley; Callahan, Margaret; Wong, Phillip; Singer, Sam; Ariyan, Charlotte; Bartlett, Edmund K; Crago, Aimee; Yoon, Sam; Hwang, Sinchun; Erinjeri, Joseph P; Qin, Li-Xuan; Tap, William D; D'Angelo, Sandra P.
Afiliação
  • Kelly CM; Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Antonescu CR; Weill Cornell Medical College, New York, New York.
  • Bowler T; Department of Sarcoma Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Munhoz R; Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chi P; Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Dickson MA; Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gounder MM; Weill Cornell Medical College, New York, New York.
  • Keohan ML; Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Movva S; Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Dholakia R; Weill Cornell Medical College, New York, New York.
  • Ahmad H; Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Biniakewitz M; Weill Cornell Medical College, New York, New York.
  • Condy M; Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Phelan H; Weill Cornell Medical College, New York, New York.
  • Callahan M; Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Wong P; Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Singer S; Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ariyan C; Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Bartlett EK; Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Crago A; Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Yoon S; Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hwang S; Weill Cornell Medical College, New York, New York.
  • Erinjeri JP; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Qin LX; Evelyn H. Lauder Breast Center, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Tap WD; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York.
  • D'Angelo SP; Immune Monitoring Facility, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York.
JAMA Oncol ; 6(3): 402-408, 2020 03 01.
Article em En | MEDLINE | ID: mdl-31971541

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Produtos Biológicos / Terapia Viral Oncolítica / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Produtos Biológicos / Terapia Viral Oncolítica / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article